V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007648 | 290004635 | null | 59 | Palliative (P) | 2017-04-04 | 2017-04-15 | Irinotecan + Modified De Gramont | null | null | 290017566 | IRINOTECAN + MDG |
| 290007649 | 290004636 | 1.59 | 59.3 | Palliative (P) | 2014-11-12 | 2015-04-30 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 290017567 | CISPLATIN + FLUOROURACIL |
| 290007650 | 290004639 | 1.62 | 60.6 | Palliative (P) | 2014-11-29 | 2015-08-30 | FLUOROURACIL | N | N | 290017567 | FLUOROURACIL |
| 290007651 | 290004641 | null | null | null | null | 2017-11-07 | FLUOROURACIL | N | N | 290017584 | FLUOROURACIL |
| 290007652 | 290004643 | null | null | null | 2017-02-15 | 2017-03-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 290017587 | FLUOROURACIL + MITOMYCIN + RT |
| 290007653 | 290004644 | 1.69 | null | Palliative (P) | 2016-05-30 | 2016-05-31 | IMATINIB | 99 | null | 290017598 | IMATINIB |
| 290007654 | 290004648 | 1.58 | 49 | Curative (C) | 2014-09-27 | 2014-12-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 290017616 | FLUOROURACIL + MITOMYCIN + RT |
| 290007655 | 290004653 | 1.6 | 78.1 | Curative (C) | 2017-11-02 | 2017-11-07 | Capecitabine + Oxaliplatin 21day | N | N | 290017656 | CARBOPLATIN |
| 290007656 | 290004656 | 1.66 | 52.2 | Disease modification (D) | 2017-03-03 | 2017-03-16 | BALLAD Trial | 2 | null | 290017662 | FLUOROURACIL + MITOMYCIN |
| 290007657 | 290004662 | 1.65 | null | Palliative (P) | 2016-11-09 | 2016-12-26 | Capecitabine + Mitomycin | null | N | 290017684 | EOX |
| 290007658 | 290004670 | 1.67 | 79.3 | Neo-adjuvant (N) | 2015-08-10 | 2015-08-17 | TEMOZOLOMIDE | 02 | Y | 290017803 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007659 | 290004677 | 1.67 | 76.5 | null | 2017-07-28 | 2017-07-28 | Cetuximab + Radiotherapy Maint | N | null | 290017858 | FLUOROURACIL + MITOMYCIN |
| 290007660 | 290004678 | 1.63 | 84.6 | Adjuvant (A) | 2017-08-18 | 2017-09-11 | FLUOROURACIL + MITOMYCIN | N | N | 290017865 | CAPECITABINE + OXALIPLATIN |
| 290007661 | 290007915 | 1.88 | 53.5 | Adjuvant (A) | 2015-10-25 | 2015-12-20 | Capecitabine + Oxaliplatin 21day | N | N | 290017875 | CAPECITABINE |
| 290007662 | 290006982 | 0 | 84.3 | Palliative (P) | null | 2015-04-03 | CETUXIMAB + CISPLATIN + FU | N | N | 290017970 | CARBOPLATIN + CETUXIMAB + FU |
| 290007663 | 290004684 | 0 | 66 | Palliative (P) | null | 2016-04-17 | LANREOTIDE | N | N | 290017974 | CARBOPLATIN + CETUXIMAB + FU |
| 290007664 | 290004686 | 1.79 | 81.6 | null | 2014-11-19 | 2014-12-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 290017985 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290007665 | 290004689 | 1.95 | 74.1 | Curative (C) | 2015-03-31 | 2015-04-05 | Cisplatin + Radiotherapy | N | null | 290018015 | FLUOROURACIL + MITOMYCIN |
| 290007666 | 290004691 | 1.69 | 73.1 | null | null | 2018-08-31 | Sunitinib | N | N | 290018024 | LANREOTIDE |
| 290007667 | 290004692 | 1.7 | 71 | Adjuvant (A) | 2016-04-13 | 2016-04-13 | BALLAD Trial | N | N | 290018029 | CISPLATIN + RT |
| 290007668 | 290004695 | 1.58 | 68.8 | Curative (C) | 2018-03-14 | 2018-03-22 | Bevacizumab 15mg/kg | 02 | N | 290018031 | CETUXIMAB |
| 290007669 | 290006986 | null | 90.2 | Palliative (P) | 2015-11-30 | 2015-11-30 | Cisplatin 7 day | 2 | N | 290018051 | CAPECITABINE + CISPLATIN |
| 290007670 | 290007918 | 0 | 86.3 | Palliative (P) | 2016-06-18 | 2016-07-23 | CAPECITABINE + OXALIPLATIN | 02 | N | 290018070 | DOCETAXEL |
| 290007671 | 290004699 | null | 84.25 | Curative (C) | 2016-11-02 | 2016-11-04 | Capecitabine + Oxaliplatin 21day | N | N | 290018074 | CETUXIMAB |
| 290007672 | 290004703 | 1.6 | null | Palliative (P) | null | 2015-09-17 | Bevacizumab + Irinotecan + MdG | N | N | 290018167 | TRIAL |
| 290007673 | 290004709 | null | 53.6 | Palliative (P) | 2015-12-24 | 2016-01-27 | Capecitabine (14 day) + Irinotecan | 02 | Y | 290018181 | TEMOZOLOMIDE |
| 290007674 | 290004711 | 1.72 | 70.5 | null | 2017-06-19 | 2017-06-19 | REGORAFENIB | N | Y | 290018198 | CAPECITABINE + CARBOPLATIN |
| 290007675 | 290004713 | 1.83 | 90.6 | null | null | 2018-11-15 | CARBOPLATIN + PACLITAXEL | N | N | 290018209 | CAPECITABINE + CARBOPLATIN |
| 290007676 | 290004718 | 1.7 | 80.8 | Palliative (P) | 2017-03-16 | 2017-03-17 | Irinotecan | N | Y | 290018235 | GEMCITABINE |
| 290007677 | 290004719 | 1.7 | 60.3 | Curative (C) | 2018-05-15 | 2018-05-25 | Capecitabine + Cisplatin | 02 | N | 290018245 | CAPECITABINE + CISPLATIN |
| 290007678 | 290006994 | 1.52 | 86 | Curative (C) | 2014-10-25 | 2015-04-05 | null | 02 | N | 290018248 | CISPLATIN |
| 290007679 | 290004726 | 1.75 | 92.1 | null | 2017-08-12 | 2017-09-04 | CAPECITABINE + IRINOTECAN | N | null | 290018249 | PEMBROLIZUMAB |
| 290007680 | 290004729 | 1.76 | null | Curative (C) | 2016-11-03 | 2016-12-27 | Trastuzumab Subcutaneous | N | null | 290018257 | BALLAD TRIAL |
| 290007681 | 290004731 | 1.78 | 90.4 | Palliative (P) | 2015-06-29 | 2015-06-30 | Capecitabine + Cisplatin | N | N | 290018280 | CAPECITABINE + IRINOTECAN |
| 290007682 | 290004734 | 0 | 0 | Palliative (P) | 2015-12-31 | 2016-02-13 | Capecitabine + Cisplatin | 2 | N | 290018284 | CAPECITABINE + CISPLATIN + RT |
| 290007683 | 290004737 | 1.75 | 105.6 | Curative (C) | 2016-03-30 | 2016-04-17 | Y-90 | N | Y | 290018295 | CETUXIMAB + RT |
| 290007684 | 290004738 | 1.77 | 77.7 | Curative (C) | 2018-04-17 | 2018-05-07 | Carboplatin+Fluorouracil 4 or 5 day | 02 | Y | 290018303 | METHOTREXATE INTRATHECAL |
| 290007685 | 290004740 | 1.65 | 75.8 | Curative (C) | null | 2018-04-06 | MCX | 2 | N | 290018309 | CAPECITABINE + RT |
| 290007686 | 290004742 | 0 | 56 | Palliative (P) | 2017-12-06 | 2017-12-06 | CETUXIMAB + RT | 02 | null | 290018327 | CARBOPLATIN + PEMETREXED |
| 290007688 | 290004747 | null | 60 | Palliative (P) | 2016-11-19 | 2016-11-24 | CARBOPLATIN + PACLITAXEL | N | N | 290018357 | DOCETAXEL |
| 290007689 | 290004748 | 0 | 73.2 | null | 2017-02-16 | 2017-02-16 | null | N | Y | 290018365 | TRIAL |
| 290007690 | 290004750 | 1.46 | 52.55 | Neo-adjuvant (N) | 2015-09-05 | 2015-12-25 | Capecitabine 42days + RT | 02 | N | 290018400 | CAPECITABINE + OXALIPLATIN |
| 290007691 | 290004753 | 1.68 | 44.7 | Palliative (P) | 2015-05-09 | 2015-05-09 | Capecitabine 35days + RT | 02 | N | 290018407 | LANREOTIDE |
| 290007693 | 290004755 | 1.77 | null | Palliative (P) | 2015-06-17 | 2015-06-17 | Capecitabine + Mitomycin | 02 | N | 290018420 | OCTREOTIDE |
| 290007694 | 290004758 | 1.8 | 90.6 | Palliative (P) | 2018-10-16 | 2018-10-22 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290018433 | CAPECITABINE + OXALIPLATIN |
| 290007695 | 290004760 | 1.66 | 55 | Disease modification (D) | 2015-01-29 | 2015-02-26 | REGORAFENIB | 2 | N | 290018450 | IGEV R |
| 290007696 | 290007926 | 1.8 | 83.2 | Palliative (P) | 2016-06-13 | 2018-11-09 | Trial Unspecified | 02 | N | 290018451 | INTERAACT TRIAL |
| 290007697 | 290007926 | 1.6 | 72 | Disease modification (D) | 2015-04-14 | 2015-04-14 | Cisplatin + Radiotherapy | 02 | N | 290018451 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 290007698 | 290004763 | 1.7 | null | Palliative (P) | 2017-08-04 | 2017-08-12 | Docetaxel 75mg/m2 (21 day) | N | N | 290018470 | CAPECITABINE + CISPLATIN |
| 290007699 | 290008400 | 1.78 | 84.5 | Palliative (P) | 2013-09-02 | 2013-11-16 | Sunitinib | 02 | N | 290018476 | CAPECITABINE |